RETRACTED: MicroRNA-326 Functions as a Tumor Suppressor in Breast Cancer by Targeting ErbB/PI3K Signaling Pathway

Ghaemi, Zahra; Soltani, Bahram Mohammad; Mowla, Seyed Javad

doi:10.3389/fonc.2019.00653

ORIGINAL RESEARCH article

Front. Oncol. , 30 July 2019

Sec. Molecular and Cellular Oncology

Volume 9 - 2019 | https://doi.org/10.3389/fonc.2019.00653

RETRACTED: MicroRNA-326 Functions as a Tumor Suppressor in Breast Cancer by Targeting ErbB/PI3K Signaling Pathway

Retracted

A retraction of this article was approved in:

Retraction: MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway
1. Read retraction

$\nZahra Ghaemi$ Zahra Ghaemi

Bahram Mohammad Soltani^*

Seyed Javad Mowla

Department of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Ghaemi Z, Soltani BM and Mowla SJ (2019) MicroRNA-326 Functions as a Tumor Suppressor in Breast Cancer by Targeting ErbB/PI3K Signaling Pathway. Front. Oncol. 9:653. doi: 10.3389/fonc.2019.00653

Received: 07 December 2018; Accepted: 03 July 2019;
Published: 30 July 2019; Retracted: 06 October 2023.

Edited by:

Valeria Poli, University of Turin, Italy

Reviewed by:

Hua Zhang, Guangdong Medical University, China
Fahd Al-Mulla, Genatak, Kuwait

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

RETRACTED: MicroRNA-326 Functions as a Tumor Suppressor in Breast Cancer by Targeting ErbB/PI3K Signaling Pathway

94% of researchers rate our articles as excellent or good

94% of researchers rate our articles as excellent or good